Connect with us

Opinion

Covid Lockdowns are Overly Blunt and Costly

New evidence suggests lockdowns were an overly blunt and economically costly tool. They are politically difficult to keep in place for long enough to stamp out the virus.

Published

on

In response to the novel and deadly coronavirus, many governments deployed draconian tactics never used in modern times: severe and broad restrictions on daily activity that helped send the world into its deepest peacetime slump since the Great Depression.

The equivalent of 400 million jobs have been lost world-wide, 13 million in the U.S. alone.

Global output is on track to fall 5% this year, far worse than during the financial crisis, according to the International Monetary Fund. Despite this steep price, few policy makers felt they had a choice, seeing the economic crisis as a side effect of the health crisis.

They ordered nonessential businesses closed and told people to stay home, all without the extensive analysis of benefits and risks that usually precedes a new medical treatment.

There wasn’t time to gather that sort of evidence: Faced with a poorly understood and rapidly spreading pathogen, they prioritized saving lives.

Five months later, the evidence suggests lockdowns were an overly blunt and economically costly tool. They are politically difficult to keep in place for long enough to stamp out the virus.

The evidence also points to alternative strategies that could slow the spread of the epidemic at much less cost. As cases flare up throughout the U.S., some experts are urging policy makers to pursue these more targeted restrictions and interventions rather than another crippling round of lockdowns.

New Thinking on Covid Lockdowns: They’re Overly Blunt and Costly – WSJ

Click to comment

Leave a Reply

Opinion

3 ways Asia can recover from the COVID-19 pandemic faster

Countries in the East Asia and Pacific region will benefit from cooperation in three major areas: vaccine deployment, reviving sectors of the regional economy, and building on their close integration into global value chains

Published

on

Don Mueang Bangkok domestic airport

For decades, East Asia and the Pacific region sustained rapid economic growth while lifting hundreds of millions out of poverty.

(more…)
Continue Reading

Opinion

Thailand’s Vaccine Strategy: What went wrong?

Questions are being asked, and not answered, over the decision to rely almost entirely on Siam Bioscience, a local, palace-owned company with no experience of making vaccines, for the country’s vaccine needs, until an unseemly scramble began this year to procure alternatives.

Published

on

Last year Thailand won worldwide praise for its effective measures to contain COVID-19. This year the government is facing growing public outrage over the failure to control new covid outbreaks, and the slow acquisition of vaccines.

(more…)
Continue Reading